| |
| |
|
| Insider
Information: |
Meline David W |
| Relationship: |
|
| City: |
St Paul |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
133,659 |
|
|
Indirect Shares
|
1,187 |
|
|
| Direct
Value |
$16,511,496 |
|
|
|
Indirect Value
|
$109,002 |
|
|
| Total
Shares |
134,846 |
|
|
| Total
Value |
$16,620,498 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -67.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
3M Co |
MMM |
Former Sr. VP & CFO |
2014-04-30 |
30,734 |
2014-04-30 |
1,187 |
Premium* |
|
|
TRW Automotive Holdings Corp |
TRW |
Director |
2015-05-15 |
0 |
2014-05-13 |
0 |
Premium* |
|
|
Amgen Inc |
AMGN |
EVP & CFO |
2019-11-25 |
49,378 |
2014-08-01 |
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
Chief Financial Officer |
2022-08-10 |
2,857 |
|
0 |
Premium* |
|
|
Pacific Biosciences Of Californi... |
PACB |
Director |
2024-03-06 |
40,000 |
2024-03-06 |
0 |
Premium* |
|
|
HP Inc |
HPQ |
|
2024-04-22 |
10,690 |
2024-04-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HPQ |
HP Inc |
|
• • – |
2024-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
7,943 |
10,690 |
0 |
- |
|
| PACB |
Pacific Biosciences Of Ca... |
Director |
– • – |
2024-03-06 |
4 |
B |
$4.40 |
$176,160 |
D/D |
40,000 |
40,000 |
2.39 |
% |
|
| MRNA |
Moderna, Inc. |
Chief Financial Officer |
• • – |
2022-08-10 |
4 |
S |
$173.66 |
$28,481 |
D/D |
(164) |
2,857 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial Officer |
• • – |
2022-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
348 |
3,021 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial OfficerOfficer |
• – – |
2022-05-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,583 |
|
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial Officer |
• • – |
2022-05-10 |
4 |
S |
$133.71 |
$20,859 |
D/D |
(156) |
2,583 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial Officer |
• • – |
2022-05-09 |
4 |
OE |
$134.40 |
$46,771 |
D/D |
348 |
2,739 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial Officer |
• • – |
2022-02-10 |
4 |
S |
$158.89 |
$98,354 |
D/D |
(619) |
2,391 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial Officer |
• • – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,392 |
3,010 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-06-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,500 |
|
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-11-25 |
4 |
S |
$234.36 |
$2,047,603 |
D/D |
(8,737) |
49,378 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,511 |
57,903 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-05-03 |
4 |
D |
$176.50 |
$140,318 |
D/D |
(795) |
53,392 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-05-01 |
4 |
D |
$179.32 |
$133,775 |
D/D |
(746) |
54,187 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-03-22 |
4 |
D |
$191.89 |
$1,542,796 |
D/D |
(8,040) |
54,933 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,086 |
62,746 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2019-01-30 |
4 |
D |
$192.11 |
$101,434 |
D/D |
(528) |
46,660 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2018-08-01 |
4 |
D |
$196.55 |
$1,450,932 |
D/D |
(7,382) |
52,202 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2018-05-03 |
4 |
D |
$169.43 |
$130,969 |
D/D |
(773) |
59,382 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2018-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,508 |
60,155 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2018-03-23 |
4 |
D |
$176.08 |
$1,329,228 |
D/D |
(7,549) |
55,647 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2018-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,118 |
62,913 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2018-01-30 |
4 |
D |
$198.00 |
$98,208 |
D/D |
(496) |
47,795 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2017-08-01 |
4 |
D |
$174.51 |
$1,319,645 |
D/D |
(7,562) |
47,920 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,305 |
55,227 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
